- Home
- BDSX vs ZYXI Comparison
BDSX vs ZYXI Comparison
Compare BDSX & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- ZYXI
- Stock Information
- Founded
- BDSX 2005
- ZYXI 1996
- Country
- BDSX United States
- ZYXI United States
- Employees
- BDSX N/A
- ZYXI N/A
- Industry
- BDSX Precision Instruments
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BDSX Health Care
- ZYXI Health Care
- Exchange
- BDSX Nasdaq
- ZYXI Nasdaq
- Market Cap
- BDSX 257.0M
- ZYXI 257.1M
- IPO Year
- BDSX 2020
- ZYXI N/A
- Fundamental
- Price
- BDSX $1.69
- ZYXI $7.90
- Analyst Decision
- BDSX Strong Buy
- ZYXI Strong Buy
- Analyst Count
- BDSX 4
- ZYXI 2
- Target Price
- BDSX $3.08
- ZYXI $14.00
- AVG Volume (30 Days)
- BDSX 239.8K
- ZYXI 93.7K
- Earning Date
- BDSX 11-05-2024
- ZYXI 10-24-2024
- Dividend Yield
- BDSX N/A
- ZYXI N/A
- EPS Growth
- BDSX N/A
- ZYXI N/A
- EPS
- BDSX N/A
- ZYXI 0.18
- Revenue
- BDSX $60,902,000.00
- ZYXI $193,614,000.00
- Revenue This Year
- BDSX $48.06
- ZYXI $11.68
- Revenue Next Year
- BDSX $29.97
- ZYXI $20.90
- P/E Ratio
- BDSX N/A
- ZYXI $43.58
- Revenue Growth
- BDSX 46.25
- ZYXI 9.11
- 52 Week Low
- BDSX $1.15
- ZYXI $7.04
- 52 Week High
- BDSX $2.21
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- BDSX 44.40
- ZYXI 46.50
- Support Level
- BDSX $1.66
- ZYXI $7.70
- Resistance Level
- BDSX $1.80
- ZYXI $8.45
- Average True Range (ATR)
- BDSX 0.08
- ZYXI 0.31
- MACD
- BDSX -0.01
- ZYXI -0.02
- Stochastic Oscillator
- BDSX 38.46
- ZYXI 22.47
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.